Advanced CCNE1-amplified solid tumors
Clinical trials for Advanced CCNE1-amplified solid tumors explained in plain language.
Never miss a new study
Get alerted when new Advanced CCNE1-amplified solid tumors trials appear
Sign up with your email to follow new studies for Advanced CCNE1-amplified solid tumors, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to control advanced breast cancer
Disease control Recruiting nowThis study tests a new drug called ECI830, alone or with other cancer drugs (ribociclib and fulvestrant), in people with advanced hormone receptor-positive, HER2-negative breast cancer or certain solid tumors. The goal is to find safe doses and see if the combination can slow can…
Matched conditions: ADVANCED CCNE1-AMPLIFIED SOLID TUMORS
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control Recruiting nowThis study tests a new drug called GVV858, alone or with hormone therapy, in people with advanced hormone receptor-positive, HER2-negative breast cancer and other solid tumors. The goal is to find the safest dose and see how well it works. About 205 adults whose cancer has progre…
Matched conditions: ADVANCED CCNE1-AMPLIFIED SOLID TUMORS
Phase 1/2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC